Exact Mass: 405.2991

Exact Mass Matches: 405.2991

Found 175 metabolites which its exact mass value is equals to given mass value 405.2991, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Minopentol

Aminopentol

C22H47NO5 (405.3454)


   

Cassaine

NCI60_041577

C24H39NO4 (405.2879)


A tricyclic diterpenoid isolated from several plant species of the genus Erythrophleum.

   

Astromicin

Fortimicin A

C17H35N5O6 (405.2587)


An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

   

10,11-Epoxy-3-geranylgeranylindole

10,11-Epoxy-3-geranylgeranylindole

C28H39NO (405.3031)


   

Emindole SB

Emindole SB

C28H39NO (405.3031)


   

3-Deoxo-4b-deoxypaxilline

12-Demethyl-11,12-dehydropaspaline

C27H35NO2 (405.2668)


   

N-Arachidonoyl Threonine

3-Hydroxy-2-[(1-hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]butanoate

C24H39NO4 (405.2879)


N-arachidonoyl threonine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Threonine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Threonine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Threonine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Aminopentol

2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol

C22H47NO5 (405.3454)


   

Astromicin

2-amino-N-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylacetamide

C17H35N5O6 (405.2587)


   

Diterpene alkaloid

2-(Dimethylamino)ethyl 2-(7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-tetradecahydrophenanthren-2-ylidene)acetic acid

C24H39NO4 (405.2879)


   

Minaxolone

1-[17-(dimethylamino)-4-ethoxy-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]ethan-1-one

C25H43NO3 (405.3243)


   

N-(4-Methoxyphenyl)-all-trans-retinamide

N-(4-methoxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

C27H35NO2 (405.2668)


   

Petromindole

Petromindole

C28H39NO (405.3031)


   

Thiersindole A

Thiersindole A

C28H39NO (405.3031)


   

Thiersindole C

Thiersindole C

C28H39NO (405.3031)


   

Emindole DA

Emindole DA

C28H39NO (405.3031)


   

Thiersindole B

Thiersindole B

C28H39NO (405.3031)


   
   
   
   
   

N-[(S)-1-Phenylethyl]-labda-7,12(E),14-triene-17-amide

N-[(S)-1-Phenylethyl]-labda-7,12(E),14-triene-17-amide

C28H39NO (405.3031)


   

ent-Ircinialactam C

ent-Ircinialactam C

C23H35NO5 (405.2515)


   

(-)-emeniveol|emeniveol

(-)-emeniveol|emeniveol

C28H39NO (405.3031)


   

10-formamido-kalihinol F

10-formamido-kalihinol F

C23H39N3O3 (405.2991)


   

8-O-methylsachaconitine

8-O-methylsachaconitine

C24H39NO4 (405.2879)


   

SCHEMBL8371124

SCHEMBL8371124

C24H39NO4 (405.2879)


   
   

14-dehydrotalatisamine

14-dehydrotalatisamine

C23H35NO5 (405.2515)


   

10,23-dihydro-24,25-dehydroaflavinine

10,23-dihydro-24,25-dehydroaflavinine

C28H39NO (405.3031)


   

N-(3,4-Dimethoxybenzyl)hexadecanamide

N-(3,4-Dimethoxybenzyl)hexadecanamide

C25H43NO3 (405.3243)


   

22alpha,23alpha-epoxy-10-epi-solanida-1,4,9-trien-3-one

22alpha,23alpha-epoxy-10-epi-solanida-1,4,9-trien-3-one

C27H35NO2 (405.2668)


   

17-hydroxydaphnigraciline

17-hydroxydaphnigraciline

C23H35NO5 (405.2515)


   

17-hydroxyeujindole

17-hydroxyeujindole

C28H39NO (405.3031)


   
   

14-dehydrogenicunin B

14-dehydrogenicunin B

C23H35NO5 (405.2515)


   

daphlongamine D

daphlongamine D

C23H35NO5 (405.2515)


   
   
   
   
   

(2E,4E,14E)-13-hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one

NCGC00380898-01!(2E,4E,14E)-13-hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one

C25H43NO3 (405.3243)


   

C28H39NO_2-Naphthalenol, decahydro-5-(1H-indol-3-ylmethyl)-1,4a-dimethyl-6-methylene-1-(4-methyl-3-penten-1-yl)-, (1S,2S,4aR,5R,8aR)

NCGC00380796-01_C28H39NO_2-Naphthalenol, decahydro-5-(1H-indol-3-ylmethyl)-1,4a-dimethyl-6-methylene-1-(4-methyl-3-penten-1-yl)-, (1S,2S,4aR,5R,8aR)-

C28H39NO (405.3031)


   

(±)N-(2-fluro-ethyl)-2,16-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,16-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C26H44FNO (405.3407)


   

(±)N-(2-fluro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C26H44FNO (405.3407)


   

(±)N-(2-fluro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C26H44FNO (405.3407)


   

NAG-3H-ABA

4-[[(3-hydroxy)-1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]amino]-butanoic acid

C24H39NO4 (405.2879)


   

P-Nitrophenyl stearate

P-Nitrophenyl stearate

C24H39NO4 (405.2879)


   

(+/-)N-(2-fluro-ethyl)-2,16-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(+/-)-2,16,-dimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

C26H44FNO (405.3407)


   

(+/-)N-(2-fluro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(+/-)-2,17,-dimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

C26H44FNO (405.3407)


   

(+/-)-2-methyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)-2-methyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

C26H44FNO (405.3407)


   

12-HETE-GABA

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-gamma-aminobutyric acid

C24H39NO4 (405.2879)


   

15-HETE-GABA

N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-gamma-aminobutyric acid

C24H39NO4 (405.2879)


   

12-oxo-PDA-Ile

N-(1S,2S)-3-oxo-2-(2Z-pentenyl)cyclopent-4-eneoctanyl isoleucine

C24H39NO4 (405.2879)


   

(+/-)-2,16,-dimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

(+/-)-2,16,-dimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

C26H44NOF (405.3407)


   

(+/-)N-(2-fluoro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(+/-)N-(2-fluoro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C26H44NOF (405.3407)


   

(+/-)-2-methyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)N-(2-fluoro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C26H44NOF (405.3407)


   

NA 24:5;O3

N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-gamma-aminobutyric acid

C24H39NO4 (405.2879)


   

NAT 19:0

N-nonadecanoyl taurine

C21H43NO4S (405.2913)


   

NA 25:4;O2

N-hexadecanoyl 3,4-dimethoxybenzylamine

C25H43NO3 (405.3243)


   

Urea, N-cyclohexyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-pyridinylmethyl)- (9CI)

Urea, N-cyclohexyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-pyridinylmethyl)- (9CI)

C24H31N5O (405.2528)


   

Bencyclane fumarate

3-(1-benzylcycloheptyl)oxy-N,N-dimethylpropan-1-amine,(E)-but-2-enedioic acid

C23H35NO5 (405.2515)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

O-NITROPHENYL STEARATE

O-NITROPHENYL STEARATE

C24H39NO4 (405.2879)


   

4-Nitrophenyl stearate

4-Nitrophenyl stearate

C24H39NO4 (405.2879)


   

1-[(2S,3S,5S,8S,9S,10S,11R,13S,14S,17S)-11-(dimethylamino)-2-ethoxy-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone

1-[(2S,3S,5S,8S,9S,10S,11R,13S,14S,17S)-11-(dimethylamino)-2-ethoxy-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone

C25H43NO3 (405.3243)


   

N-Decyl-N,N-dimethyldecan-1-aminium bromide

N-Decyl-N,N-dimethyldecan-1-aminium bromide

C22H48BrN (405.297)


   
   

N-(4-Methoxyphenyl)-all-trans-retinamide

N-(4-Methoxyphenyl)-all-trans-retinamide

C27H35NO2 (405.2668)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   
   

3-Hydroxy-4-(icosa-5,8,11,14-tetraenoylamino)butanoic acid

3-Hydroxy-4-(icosa-5,8,11,14-tetraenoylamino)butanoic acid

C24H39NO4 (405.2879)


   

2-[trans-(4-Aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurine

2-[trans-(4-Aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurine

C23H31N7 (405.2641)


   

N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide

N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide

C21H35N5O3 (405.274)


   

3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate

3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate

C24H37O5- (405.2641)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholanate

3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholanate

C24H37O5- (405.2641)


   

7alpha,12alpha-Dihydroxy-3-oxo-5beta-cholan-24-Oate

7alpha,12alpha-Dihydroxy-3-oxo-5beta-cholan-24-Oate

C24H37O5- (405.2641)


A bile acid anion that is the conjugate base of 7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Diterpene alkaloid

Diterpene alkaloid

C24H39NO4 (405.2879)


   

N-Arachidonoyl Threonine

N-Arachidonoyl Threonine

C24H39NO4 (405.2879)


   

N-[[4-(diethylamino)phenyl]methyl]-1-[2-(1-piperidinyl)ethyl]-2-benzimidazolamine

N-[[4-(diethylamino)phenyl]methyl]-1-[2-(1-piperidinyl)ethyl]-2-benzimidazolamine

C25H35N5 (405.2892)


   

22alpha,23alpha-Epoxy-solanida-1,4,9-trien-3-one

22alpha,23alpha-Epoxy-solanida-1,4,9-trien-3-one

C27H35NO2 (405.2668)


A natural product found in Solanum campaniforme.

   

3alpha,7beta-Dihydroxy-12-oxo-5beta-cholanate

3alpha,7beta-Dihydroxy-12-oxo-5beta-cholanate

C24H37O5- (405.2641)


   

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C22H35N3O4 (405.2627)


   

(2E,4E,14E)-13-Hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one

(2E,4E,14E)-13-Hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one

C25H43NO3 (405.3243)


   
   
   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexadeca-7,10,13-trienamide

C25H43NO3 (405.3243)


   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxynonan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxynonan-2-yl)hexadeca-4,7,10,13-tetraenamide

C25H43NO3 (405.3243)


   

(E)-2-(decanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

C20H39NO5S (405.2549)


   
   

SPHP(21:1)

SPHP(m21:1)

C21H44NO4P (405.3008)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SPHP(20:2)

SPHP(d20:2)

C20H40NO5P (405.2644)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-DOPA 14:1(9Z)

NA-DOPA 14:1(9Z)

C23H35NO5 (405.2515)


   

NA-Dopamine 17:0

NA-Dopamine 17:0

C25H43NO3 (405.3243)


   

NA-Glu 18:4(6Z,9Z,12Z,15Z)

NA-Glu 18:4(6Z,9Z,12Z,15Z)

C23H35NO5 (405.2515)


   

NA-His 17:1(9Z)

NA-His 17:1(9Z)

C23H39N3O3 (405.2991)


   

NA-Taurine 19:0

NA-Taurine 19:0

C21H43NO4S (405.2913)


   

NA-Thr 20:4(5Z,8Z,11Z,14Z)

NA-Thr 20:4(5Z,8Z,11Z,14Z)

C24H39NO4 (405.2879)


   
   

NA-Val 20:3(8Z,11Z,14Z)

NA-Val 20:3(8Z,11Z,14Z)

C25H43NO3 (405.3243)


   
   

Cer 9:0;O2/16:4

Cer 9:0;O2/16:4

C25H43NO3 (405.3243)


   

ST 21:2;O3;Gly

ST 21:2;O3;Gly

C23H35NO5 (405.2515)


   

ST 22:1;O2;Gly

ST 22:1;O2;Gly

C24H39NO4 (405.2879)


   

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

C24H39NO4 (405.2879)


   

(1s,2s,4ar,5s,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

(1s,2s,4ar,5s,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

C23H35NO5 (405.2515)


   

methyl (1'r,3r,5's,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

methyl (1'r,3r,5's,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

C23H35NO5 (405.2515)


   

(4s,6s,8s,10s,11e,13e,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

(4s,6s,8s,10s,11e,13e,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

C24H39NO4 (405.2879)


   

(2e,5z,8s,10s,12s,14s)-8,10,12,14-tetramethoxy-2,5-dimethyl-7-methylideneheptadeca-2,5,16-trienenitrile

(2e,5z,8s,10s,12s,14s)-8,10,12,14-tetramethoxy-2,5-dimethyl-7-methylideneheptadeca-2,5,16-trienenitrile

C24H39NO4 (405.2879)


   

(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol

(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol

C28H39NO (405.3031)


   

7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol

7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol

C28H39NO (405.3031)


   

(1s,2s,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

(1s,2s,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

C28H39NO (405.3031)


   

(1s,4r,4as,7r,7as,11as)-8-(1h-indol-3-yl)-9-isopropyl-4,4a,7-trimethyl-1h,2h,3h,4h,5h,6h,7h,7ah,10h,11h-cyclohexa[e]naphthalen-1-ol

(1s,4r,4as,7r,7as,11as)-8-(1h-indol-3-yl)-9-isopropyl-4,4a,7-trimethyl-1h,2h,3h,4h,5h,6h,7h,7ah,10h,11h-cyclohexa[e]naphthalen-1-ol

C28H39NO (405.3031)


   

(2r,3r,4s,7r,8s,11r,12r,15s)-4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol

(2r,3r,4s,7r,8s,11r,12r,15s)-4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol

C28H39NO (405.3031)


   

(1s,2s,4as,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

(1s,2s,4as,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

11-ethyl-9-hydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

11-ethyl-9-hydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

C23H35NO5 (405.2515)


   

(1s,2r,3s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

(1s,2r,3s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

C23H35NO5 (405.2515)


   

(1r,4as,4br,7r,8s,8ar,10as)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

(1r,4as,4br,7r,8s,8ar,10as)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

C28H39NO (405.3031)


   

(1r,2s,3r,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

(1r,2s,3r,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

C23H35NO5 (405.2515)


   

2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide

2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide

C17H35N5O6 (405.2587)


   

5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

methyl (1'r,3r,5'r,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

methyl (1'r,3r,5'r,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

C23H35NO5 (405.2515)


   

(1s,2s,4ar,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

(1s,2s,4ar,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

C28H39NO (405.3031)


   

(2s,5s,6r,9s,11r,14r,15s)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

(2s,5s,6r,9s,11r,14r,15s)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

C28H39NO (405.3031)


   

(1s,4r,8r)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

(1s,4r,8r)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

C28H39NO (405.3031)


   

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C23H35NO5 (405.2515)


   

4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol

4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol

C28H39NO (405.3031)


   

8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

C28H39NO (405.3031)


   

(1s,2s,3r,5r,7s,10r,11s,12r,13r,14s,16r,17r,18s,19s)-4-ethyl-12,16-dimethoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol

(1s,2s,3r,5r,7s,10r,11s,12r,13r,14s,16r,17r,18s,19s)-4-ethyl-12,16-dimethoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol

C23H35NO5 (405.2515)


   

8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

C28H39NO (405.3031)


   

(1s,4r,4as,7r,7as,8s,9r,11as)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

(1s,4r,4as,7r,7as,8s,9r,11as)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

C28H39NO (405.3031)


   

(1r,4s,4ar,7s,7ar,8r,9s,11ar)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

(1r,4s,4ar,7s,7ar,8r,9s,11ar)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

C28H39NO (405.3031)


   

(1s,2r,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

(1s,2r,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

C28H39NO (405.3031)


   

(3r,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid

(3r,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid

C23H35NO5 (405.2515)


   

(1r,4ar,4br,7r,8s,8as,10ar)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

(1r,4ar,4br,7r,8s,8as,10ar)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one

C28H39NO (405.3031)


   

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C23H35NO5 (405.2515)


   

1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol

1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol

C28H39NO (405.3031)


   

n-(6-hydroxy-1,6-dimethyl-4-{2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl}-5-(methylideneamino)-octahydronaphthalen-1-yl)carboximidic acid

n-(6-hydroxy-1,6-dimethyl-4-{2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl}-5-(methylideneamino)-octahydronaphthalen-1-yl)carboximidic acid

C23H39N3O3 (405.2991)


   

methyl 6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

methyl 6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate

C23H35NO5 (405.2515)


   

11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

C23H35NO5 (405.2515)


   

(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol

(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol

C28H39NO (405.3031)


   

(1s,2s,4ar,5s,8ar)-5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

(1s,2s,4ar,5s,8ar)-5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

(3s,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid

(3s,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid

C23H35NO5 (405.2515)


   

n-{2-[(2s,5r)-5-[(1s,4s,4as,7r,8r,8as)-7-hydroxy-4,7-dimethyl-4,8-bis(methylideneamino)-octahydronaphthalen-1-yl]-5-methyloxolan-2-yl]propan-2-yl}carboximidic acid

n-{2-[(2s,5r)-5-[(1s,4s,4as,7r,8r,8as)-7-hydroxy-4,7-dimethyl-4,8-bis(methylideneamino)-octahydronaphthalen-1-yl]-5-methyloxolan-2-yl]propan-2-yl}carboximidic acid

C23H39N3O3 (405.2991)


   

5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)


   

(4s,6s,8s,10s,11e,13e,15z)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

(4s,6s,8s,10s,11e,13e,15z)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

C24H39NO4 (405.2879)


   

(1s,4r,4as,8r,8as)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

(1s,4r,4as,8r,8as)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol

C28H39NO (405.3031)


   

2-{1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl}propan-2-ol

2-{1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl}propan-2-ol

C27H35NO2 (405.2668)


   

(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyheptadeca-4,6,9-trienimidic acid

(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyheptadeca-4,6,9-trienimidic acid

C24H39NO4 (405.2879)


   

5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol

C28H39NO (405.3031)


   

(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol

(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol

C28H39NO (405.3031)


   

n-[(1s,4s,4as,5r,6r,8as)-6-hydroxy-1,6-dimethyl-4-[(2r,5s)-2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl]-5-(methylideneamino)-octahydronaphthalen-1-yl]carboximidic acid

n-[(1s,4s,4as,5r,6r,8as)-6-hydroxy-1,6-dimethyl-4-[(2r,5s)-2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl]-5-(methylideneamino)-octahydronaphthalen-1-yl]carboximidic acid

C23H39N3O3 (405.2991)


   

2-(dimethylamino)ethyl 2-[(1r,2e,4ar,4br,7s,8ar,10as)-7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-decahydrophenanthren-2-ylidene]acetate

2-(dimethylamino)ethyl 2-[(1r,2e,4ar,4br,7s,8ar,10as)-7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-decahydrophenanthren-2-ylidene]acetate

C24H39NO4 (405.2879)


   

(2r,5r,6s,9r,11s,14s,15r)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

(2r,5r,6s,9r,11s,14s,15r)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol

C28H39NO (405.3031)


   

n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyheptadeca-4,6,9-trienimidic acid

n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyheptadeca-4,6,9-trienimidic acid

C24H39NO4 (405.2879)


   

2-[(1s,2s,5s,7s,11r,14s)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl]propan-2-ol

2-[(1s,2s,5s,7s,11r,14s)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl]propan-2-ol

C27H35NO2 (405.2668)


   

(1s,2r,3s,5r,6s,8s,9s,10r,13s,16r,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

(1s,2r,3s,5r,6s,8s,9s,10r,13s,16r,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

C23H35NO5 (405.2515)


   

8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol

C28H39NO (405.3031)


   

7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol

7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol

C28H39NO (405.3031)


   

(4s,6s,8s,10s,11e,13z,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

(4s,6s,8s,10s,11e,13z,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene

C24H39NO4 (405.2879)


   

11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

C24H39NO4 (405.2879)


   

(1s,2s,4as,6s,8ar)-6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

(1s,2s,4as,6s,8ar)-6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol

C28H39NO (405.3031)